r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CS

Carmine N. Stengone

Insider · CEO and President · CTNM

Carmine N. Stengone files insider transactions with the SEC as a ceo and president of Contineum Therapeutics (CTNM). We hold 7 disclosed purchases and sales filed since 3 October 2023, 4 of them in the last 90 days.

  • Files forCTNM
  • Disclosed buys and sells7 in all, 4 in the last 90 days
  • Last disclosure8 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 24 May 2024 — 8 September 2026CEO and President · Contineum Therapeutics (CTNM)36 Form 4 lines · source: SEC Form 4
  • Filed 29 September 2023 — 10 June 2026Director · Kiora Pharmaceuticals (KPRX)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.